Show simple item record

dc.contributor.authorColeman, M
dc.contributor.authorKelly, D J
dc.date.accessioned2012-02-03T15:14:45Z
dc.date.available2012-02-03T15:14:45Z
dc.date.issued2012-02-03T15:14:45Z
dc.identifier.citationActa Anaesthesiol Scand. 1998 Feb;42(2):267-9.en_GB
dc.identifier.issn0001-5172 (Print)en_GB
dc.identifier.issn0001-5172 (Linking)en_GB
dc.identifier.pmid9509215en_GB
dc.identifier.urihttp://hdl.handle.net/10147/209194
dc.description.abstractA pregnant patient at 38 weeks' gestation developed symptoms of local anaesthetic toxicity following intravenous regional anaesthesia (IVRA) for hand surgery, using a standard dose of lignocaine. Reports suggest that a number of factors, both physiological and pharmacological, combine to increase the likelihood of local anaesthetic (LA) toxicity in pregnancy despite employment of a conventional "safe" IVRA technique. It is suggested that for IVRA, pregnant patients are premedicated with a benzodiazepine, the tourniquet time is increased and the concentration of LA is decreased to reduce the risks of LA toxicity.
dc.language.isoengen_GB
dc.subject.meshAdulten_GB
dc.subject.mesh*Anesthesia, Intravenousen_GB
dc.subject.meshAnesthetics, Local/*adverse effectsen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHumansen_GB
dc.subject.meshLidocaine/*adverse effectsen_GB
dc.subject.meshPregnancyen_GB
dc.titleLocal anaesthetic toxicity in a pregnant patient undergoing lignocaine-induced intravenous regional anaesthesia.en_GB
dc.contributor.departmentDepartment of Anaesthesia and Intensive Care, Cork University Hospital, Ireland.en_GB
dc.identifier.journalActa anaesthesiologica Scandinavicaen_GB
dc.description.provinceMunster
html.description.abstractA pregnant patient at 38 weeks' gestation developed symptoms of local anaesthetic toxicity following intravenous regional anaesthesia (IVRA) for hand surgery, using a standard dose of lignocaine. Reports suggest that a number of factors, both physiological and pharmacological, combine to increase the likelihood of local anaesthetic (LA) toxicity in pregnancy despite employment of a conventional "safe" IVRA technique. It is suggested that for IVRA, pregnant patients are premedicated with a benzodiazepine, the tourniquet time is increased and the concentration of LA is decreased to reduce the risks of LA toxicity.


This item appears in the following Collection(s)

Show simple item record